Maria G. Freve plans sale of 8,306 shares
Maria G. Freve filed a notice to sell up to 8,306 common shares, with an aggregate market value of $489,970.94.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Maria G. Freve filed a notice to sell up to 8,306 common shares, with an aggregate market value of $489,970.94. The shares are to be sold through Morgan Stanley Smith Barney on NASDAQ, with an approximate sale date of January 28, 2026.
These 8,306 shares were acquired on January 23, 2026 as restricted stock units from the issuer. The issuer had 113,614,046 shares outstanding. In the prior three months, Freve sold 6,667 common shares for $399,956.66 and 1,666 shares under a Rule 10b5-1 plan for $96,927.88.
Insights
Routine Rule 144 filing for RSU-related insider share sales.
The notice shows Maria G. Freve intends to sell 8,306 common shares, valued at about $489,970.94, on NASDAQ around January 28, 2026. These shares were recently acquired as restricted stock units from the issuer.
Outstanding shares total 113,614,046, suggesting the planned sale is small relative to the issuer’s equity base. The disclosure also lists prior three‑month sales of 6,667 shares for $399,956.66 and 1,666 shares under a Rule 10b5-1 plan for $96,927.88.
The activity appears consistent with ongoing equity compensation monetization. On its own, the size and nature of these transactions are typically viewed as administratively routine rather than thesis‑changing for investors.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filing disclose for SYM?
AI-generated analysis. How Rhea-AI works. Not financial advice.